Search Results - Neil Dunavin
- Showing 1 - 4 results of 4
-
1
Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer by Mitchell W Braun, Haitham Abdelhakim, Meizhang Li, Stephen Hyter, Ziyan Pessetto, Devin C Koestler, Harsh B Pathak, Neil Dunavin, Andrew K Godwin
Published in Journal for ImmunoTherapy of Cancer (2020-10-01)Get full text
Article -
2
Reduced dose pentostatin for initial management of hairy cell leukemia patients who have active infection or risk of hemorrhage is safe and effective by Leslie A. Andritsos, Neil Dunavin, Gerard Lozanski, Jeffrey A. Jones, James S. Blachly, David M. Lucas, John C. Byrd, Eric Kraut, Michael R. Grever
Published in Haematologica (2015-01-01)Get full text
Article -
3
P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS by Courtney Dinardo, Daniel Pollyea, Ahmed Aribi, Brian Jonas, Deepa Jeyakumar, Gail Roboz, Hongtao Liu, Neil Dunavin, William Blum, Alec Zhang, Yasuhiro Tabata, Donna Valencia, Tao Huang, Kyu Hong, Hong Xiang, Charlene Liao, Paul Woodard, Yazan Madanat
Published in HemaSphere (2023-08-01)Get full text
Article -
4
A phase 1 study of IO-202, an anti-LILRB4 antibody, in chronic myelomonocytic leukemia and acute myeloid leukemia by Ahmed Aribi, Gabriel N. Mannis, Yazan F. Madanat, Brian A. Jonas, Neil Dunavin, Gail J. Roboz, Deepa Jeyakumar, Guillermo Garcia-Manero, Hongtao Liu, Hetty E. Carraway, Jennifer N. Saultz, William Blum, Gary Schiller, Tao Huang, Paul Woodard, Barbara Klencke, X. Charlene Liao, Hong Xiang, Daniel A. Pollyea, Courtney D. DiNardo
Published in Blood Neoplasia (2025-11-01)Get full text
Article
